| Stage | ABBV | % of rev | CSCO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $17.4B | 100.00% | $17.3B | 100.00% | ABBV ×1.01 |
| Gross profit | $12.9B | 74.14% | $11.1B | 64.13% | ABBV +10.0pp |
| Operating income | $6.3B | 36.01% | $4.3B | 24.72% | ABBV +11.3pp |
| Pre-tax income | $4.8B | 27.75% | $4.9B | 28.59% | CSCO +0.8pp |
| Net income | $4.2B | 24.25% | $3.9B | 22.37% | ABBV +1.9pp |
| Stage | ABBV | CSCO | Gap · A − B |
|---|---|---|---|
| Revenue | $17.4B100.00% | $17.3B100.00% | ABBV ×1.01 |
| Gross profit | 74.14%$12.9B | 64.13%$11.1B | ABBV +10.0pp |
| Operating income | 36.01%$6.3B | 24.72%$4.3B | ABBV +11.3pp |
| Pre-tax income | 27.75%$4.8B | 28.59%$4.9B | CSCO +0.8pp |
| Net income |
| 24.25%$4.2B |
| 22.37%$3.9B |
| ABBV +1.9pp |
No shared counterparties.